You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 1
  • 102 Is the use of sub-cutaneous alfentanil outside the ccu setting compliant with local guidelines? a retrospective audit in a tertiary cancer centre

Article info

Article menu

Download PDFPDF

Poster presentations
Pain | Posters 101–104
102 Is the use of sub-cutaneous alfentanil outside the ccu setting compliant with local guidelines? a retrospective audit in a tertiary cancer centre
Free

Authors

Citation

Tweddle A, Most J, Halley A, et al
102 Is the use of sub-cutaneous alfentanil outside the ccu setting compliant with local guidelines? a retrospective audit in a tertiary cancer centre
BMJ Supportive & Palliative Care 2018;8:A47.

Publication history

  • First published March 1, 2018.
Online issue publication 
March 23, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions